[Federal Register Volume 68, Number 179 (Tuesday, September 16, 2003)]
[Notices]
[Pages 54249-54250]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 03-23532]


=======================================================================
-----------------------------------------------------------------------

SECURITIES AND EXCHANGE COMMISSION


Issuer Delisting; Notice of Application To Withdraw From Listing 
and Registration on the American Stock Exchange LLC (ALARIS Medical 
Systems, Inc., Common Stock, $.01 Par Value) File No. 1-10207

September 10, 2003.
    ALARIS Medical Systems, Inc., a Delaware corporation (``Issuer''), 
has filed an application with the Securities and Exchange Commission 
(``Commission''), pursuant to section 12(d) of the Securities Exchange 
Act of 1934 (``Act'') \1\ and rule 12d2-2(d) thereunder,\2\ to withdraw 
its Common Stock, $.01 par value (``Security''), from listing and 
registration on the American Stock Exchange LLC (``Amex'' or 
``Exchange'').
---------------------------------------------------------------------------

    \1\ 15 U.S.C. 78l(d).
    \2\ 17 CFR 240.12d2-2(d).
---------------------------------------------------------------------------

    The Issuer states that it wishes to withdraw its Security from 
listing and registration on the Amex and to list its Security on the 
New York Stock Exchange, Inc. (``NYSE''). The Issuer believes that the 
global recognition of the NYSE will be beneficial to the Issuer and its 
shareholders. The Issuer states that it intends to list the Security on 
the NYSE on September 25, 2003.
    The Issuer stated in its application that it has met the 
requirements of Amex Rule 18 by complying with all applicable laws in 
the State of Delaware, in which it is incorporated, and with the Amex's 
rules governing an issuer's voluntary withdrawal of a security from 
listing and registration.

[[Page 54250]]

    The Issuer's application relates solely to the withdrawal of the 
Securities from listing on the Amex and from registration under section 
12(b) of the Act \3\ shall not affect its obligation to be registered 
under section 12(g) of the Act.\4\
---------------------------------------------------------------------------

    \3\ 15 U.S.C. 78l(b).
    \4\ 15 U.S.C. 78l(g).
---------------------------------------------------------------------------

    Any interested person may, on or before October 6, 2003, submit by 
letter to the Secretary of the Securities and Exchange Commission, 450 
Fifth Street, NW., Washington, DC 20549-0609, facts bearing upon 
whether the application has been made in accordance with the rules of 
the Amex and what terms, if any, should be imposed by the Commission 
for the protection of investors. The Commission, based on the 
information submitted to it, will issue an order granting the 
application after the date mentioned above, unless the Commission 
determines to order a hearing on the matter.

    For the Commission, by the Division of Market Regulation, 
pursuant to delegated authority.\5\
---------------------------------------------------------------------------

    \5\ 17 CFR 200.30-3(a)(1).
---------------------------------------------------------------------------

Jonathan G. Katz,
Secretary.
[FR Doc. 03-23532 Filed 9-15-03; 8:45 am]
BILLING CODE 8010-01-M